| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 27 Mar 2025 | 27 Mar 2025 |
| Information about acquisition | ||
| Board Meeting | 8 Feb 2025 | 3 Feb 2025 |
| Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended 31 December 2024 1. The unaudited financial results (standalone and consolidated) of the Company for the quarter and nine months ended 31 December 2024 and the same is enclosed along with the Limited Review Report issued by the Statutory Auditors of the Company. 2. Appointment of Mr. Ravindra K S as the Chief Financial Officer with effect from 01 March 2025, who will also act as a Group Chief Financial Officer. 3. Amended Policies of the Company. (As Per Bse Announcement Dated on 08.02.2025) | ||
| Board Meeting | 20 Dec 2024 | 14 Dec 2024 |
| Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/12/2024 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 20 December 2024 at the registered office of the Company inter-alia to consider approve and take on record the unaudited standalone and consolidated financial results of the Company for the quarter and six months ended 30 September 2024. 1.Unaudited Financial Results (Standalone and Consolidated) of the Company for quarter and six months ended 30 September 2024; 2. Postal Ballot Notice for seeking shareholders approval for the ratification of Suraksha Employee Stock Option Scheme 2024 (ESOP 2024/ Scheme)3. Formation of a Special Purpose Vehicle Company (SPV) (As per BSE Announcement Dated on 20/12/2024) Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 for incorporation of Suraksha Advanced Radiology Private Limited, Subsidiary of the Company. (As Per BSE Announcement dated on 22.01.2025) | ||
Suraksha Diagnostics specializes in medical consultancy services, hoping to attract investors in the rising healthcare sector
The anchor book, available to institutional investors, will open a day earlier, on November 28, 2024.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
